Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy. (Q53062494)
Jump to navigation
Jump to search
scientific article published on 26 February 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy. |
scientific article published on 26 February 2014 |
Statements
Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy. (English)
1 reference
Stephen A Boorjian
Igor Frank
Robert F Tarrell
Prabin Thapa
R Jeffrey Karnes
R Houston Thompson
Matthew K Tollefson
26 February 2014
1 reference